Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy - Histologic findings in eight patients from an open-label pilot study
D. Baeten et al., Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy - Histologic findings in eight patients from an open-label pilot study, ARTH RHEUM, 44(1), 2001, pp. 186-195
Objective. To assess the effects of treatment with anti-tumor necrosis fact
or alpha (anti-TNF alpha) on synovial histology in patients with spondylart
hropathy (SpA) in order to confirm the effect on peripheral synovitis and t
o investigate the immunologic mechanisms involved in anti-TNF alpha therapy
.
Methods. Patients with treatment-resistant SpA were treated with infliximab
(5 mg/kg) at weeks 0, 2, and 6 in an open-label pilot study. In 8 patients
, synovial biopsy tissues obtained at baseline, week 2, and week 12 were us
ed for histologic and immunohistochemical evaluation.
Results. In all 8 patients (3 with ankylosing spondylitis, 1 with undiffere
ntiated SpA, and 4 with psoriatic arthritis), there was a clear clinical im
provement in the peripheral arthritis after anti-TNF alpha therapy. Histolo
gic analysis of the synovial biopsy tissues indicated that the synovial lin
ing layer thickness tended to decrease, with a significant reduction of CD5
5+ synoviocytes, at week 12. in the sublining layer, vascularity was reduce
d at week 12, with a decreased endothelial expression of vascular cell adhe
sion molecule 1 but not intercellular adhesion molecule 1, platelet endothe
lial cell adhesion molecule I, and E-selectin. Although at week 2 and week
12, the number of neutrophils and CD68+ macrophages in the sublining layer
was decreased, the overall degree of inflammatory infiltration remained unc
hanged. This could be related to the lymphocyte infiltration since at week
12, only CD4+ cells (but not CD3+, CD45RO+, and CD8+ cells) tended to decre
ase, while CD20+ lymphocytes and plasma cells were clearly increased.
Conclusion. The reduction in lining layer thickness, vascularity, and infil
tration with neutrophils and macrophages paralleled the beneficial effect o
f anti-TNF alpha therapy on peripheral synovitis in 8 patients with differe
nt subtypes of SpA. The adhesion molecule expression, T cell infiltration,
and, most important, B cell infiltration seemed to contrast,vith previous o
bservations in RA. Although these preliminary data need to be confirmed in
a larger cohort, they suggest distinct immunomodulatory mechanisms of anti-
TNF alpha in SpA.